PKU-led team found effective SARS-CoV-2 neutralizing antibodies
Auteur : Beijing Advanced Innovation Center for Genomics, Biomedical Pioneering Innovation Center, Peking University
Diffusion : site de l’Université de Pékin, http://english.pku.edu.cn/
Date : 18 mai 2020.
Peking University, May 18, 2020: A joint research team led by Sunney Xie, Director of Beijing Advanced Innovation Center for Genomics (ICG) at Peking University (PKU) has successfully identified multiple highly potent neutralizing antibodies against the novel coronavirus SARS-CoV-2, the causative virus of the respiratory disease COVID-19, from convalescent plasma by high-throughput single-cell sequencing. Generated by human immune system, neutralizing antibodies can effectively prevent viruses from infecting cells. New results from animal studies showed that their neutralizing antibody provides a potential cure for COVID-19 as well as means for short-term prevention. This marks a major milestone in the fight against the pandemic.
Source : Beijing Advanced Innovation Center for Genomics, Biomedical Pioneering Innovation Center, “PKU-led team found effective SARS-CoV-2 neutralizing antibodies”, Peking University, 18/05/2020. URL : http://newsen.pku.edu.cn/news_events/news/research/9779.htm (consulté le 22/05/2020).
Cette étude a été publiée dans la revue scientifique “Cell” le 17 mai 2020.
Référence : Sunney Xie, Yunlong Cao, Bin Su et al., “Potent neutralizing antibodies against SARS-CoV-2 identified by high-throughput single-cell sequencing of convalescent patients’ B cells”, Cell, 17/05/2020. DOI : https://doi.org/10.1016/j.cell.2020.05.025 (consulté le 22/05/2020) .
Photo “à la une” : Sunney Xie (in the middle) and some members of his team. © Université de Pékin.